Is immune effector cell-associated enterocolitis a CAR T-cell lymphoproliferative disorder?
Open Access
- 3 July 2025
- journal article
- other
- Published by Springer Nature in Blood Cancer Journal
- Vol. 15 (1) , 1-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibodyNature Medicine, 2025
- CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53New England Journal of Medicine, 2025
- Indolent CD8+ CAR T-Cell Lymphoma of the Gastrointestinal Tract after Ciltacabtagene Autoleucel Therapy for Relapsed/Refractory Multiple MyelomaBlood, 2024
- Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myelomaBlood Cancer Journal, 2024
- Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell TherapyNew England Journal of Medicine, 2024
- Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyNew England Journal of Medicine, 2024
- Gluten induces rapid reprogramming of natural memory αβ and γδ intraepithelial T cells to induce cytotoxicity in celiac diseaseScience Immunology, 2023
- Analysis of Circulating Food Antigen-Specific T-Cells in Celiac Disease and Inflammatory Bowel DiseaseInternational Journal of Molecular Sciences, 2023
- IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clonesThe Journal of Immunology, 1997
- A novel cytotoxicity of CD4+ Th1 clones on heat-shocked tumor targets. I. Implications for internal disintegration model for target death and hyperthermia treatment of cancersThe Journal of Immunology, 1991